Pharmacists treating hypertension patients could save US $1.1 trillion: Study

The U.S. healthcare industry could save more than $1.1 trillion and prevent about 15 million heart attacks over the next 30 years if pharmacists were more involved in hypertension care, according to research conducted by Virginia Commonwealth University in Richmond. 

Advertisement

Nearly 8 million strokes and more than 4 million cases each of angina and heart failure could also be avoided, VCU said in a news release. 

Most states allow pharmacists some prescribing powers, but reimbursement issues limit the uptake. If this barrier fell, the researchers found patients could also regain more than 30 million “quality-adjusted life years,” or years with a significantly higher quality of life without medical emergencies from high blood pressure. 

Hypertension is the leading cause of preventable deaths and disabilities worldwide, according to the study, which was published Nov. 3 in JAMA. Patients are 12 times more likely to visit pharmacies than primary care physicians, VCU said, so this pharmacist-led intervention could improve healthcare access.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.